Rapport Therapeutics, Inc. (RAPP)

Latest Insider Confidence Score

2026Q1

48.6
Bearish

Company insider confidence (by quarter)

2024Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Burow Kristina — 1,392,738 Jun 10, 2024
Nelsen Robert — 1,392,738 Jun 10, 2024
Crandell Keith — 1,392,738 Jun 10, 2024
ARCH Venture Partners XII, LLC — 1,392,738 Jun 10, 2024
ARCH Venture Fund XII, L.P. — 1,392,738 Jun 10, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 18, 2026 Feb 19, 2026 Ceesay Abraham CEO Sell 45.0 -10,916 -1.63% ✓ $320.4K
Feb 17, 2026 Feb 19, 2026 Bredt David Chief Scientific Officer Sell 42.5 -8,500 -2.15% ✓ $246.7K
Feb 2, 2026 Feb 4, 2026 Sevigny Jeffrey Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Ceesay Abraham CEO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Ignelzi Troy A. CFO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Yeleswaram Krishnaswamy Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Bredt David Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 2, 2026 Feb 4, 2026 Gault Cheryl COO Neutral 52.5 - 0.00% ✗ -
Jan 20, 2026 Jan 22, 2026 Ceesay Abraham CEO Sell 45.0 -10,916 -1.60% ✓ $285.1K
Jan 15, 2026 Jan 16, 2026 Bredt David Chief Scientific Officer Sell 42.5 -8,500 -2.10% ✓ $228.1K
Dec 31, 2025 Jan 5, 2026 Bredt David Chief Scientific Officer Sell 42.5 -24,567 -5.73% ✗ $197.3K
Dec 31, 2025 Jan 5, 2026 Yeleswaram Krishnaswamy Chief Development Officer Sell 82.5 +6,160 2.12% ✗ $85.3K
Dec 17, 2025 Dec 18, 2025 Ceesay Abraham CEO Sell 42.5 -10,916 -1.58% ✓ $323.5K
Dec 15, 2025 Dec 16, 2025 Bredt David Chief Scientific Officer Sell 38.8 -8,500 -2.12% ✓ $255.1K
Nov 26, 2025 Dec 1, 2025 Gault Cheryl COO Sell 41.3 -5,000 -2.83% ✓ $150.5K
Nov 17, 2025 Nov 18, 2025 Ceesay Abraham CEO Sell 42.5 -10,916 -1.55% ✓ $275K
Nov 17, 2025 Nov 18, 2025 Bredt David Chief Scientific Officer Sell 41.3 -8,500 -2.07% ✓ $214.1K
Oct 15, 2025 Oct 16, 2025 Bredt David Chief Scientific Officer Sell 41.3 -8,500 -2.03% ✓ $219.2K
Oct 15, 2025 Oct 16, 2025 Ceesay Abraham CEO Sell 42.5 -10,916 -1.53% ✓ $281.7K
Sep 17, 2025 Sep 19, 2025 Ceesay Abraham CEO Sell 23.8 -76,420 -9.68% ✓ $2M
Sep 15, 2025 Sep 17, 2025 Bredt David Chief Scientific Officer Sell 45.0 -8,500 -1.99% ✓ $205.6K
Sep 12, 2025 Sep 15, 2025 Huber Reid M Director Buy 97.5 +20,400 100.00% ✗ $499.4K
Sep 12, 2025 Sep 15, 2025 PAUL STEVEN M Director Buy 100.0 +41,666 100.00% ✗ $1M
Sep 11, 2025 Sep 11, 2025 Young Wendy B. Director Buy 95.0 +3,500 58.33% ✗ $79.1K
Sep 8, 2025 Sep 10, 2025 Gault Cheryl COO Sell 41.3 -5,000 -2.83% ✓ $191.7K
Aug 15, 2025 Aug 18, 2025 Bredt David Chief Scientific Officer Sell 45.0 -8,500 -1.95% ✓ $127.5K
Jul 15, 2025 Jul 16, 2025 Bredt David Chief Scientific Officer Sell 45.0 -8,500 -1.92% ✓ $119K
Jun 17, 2025 Jun 18, 2025 Sanchez Ramiro Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2025 Jun 18, 2025 Young Wendy B. Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2025 Jun 18, 2025 MARAGANORE JOHN Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2025 Jun 18, 2025 HEALY JAMES Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2025 Jun 18, 2025 PEREZ ROBERT J Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2025 Jun 18, 2025 Huber Reid M Director Neutral 52.5 - 0.00% ✗ -
Jun 17, 2025 Jun 18, 2025 PAUL STEVEN M Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Jun 18, 2025 Bredt David Chief Scientific Officer Sell 45.0 -8,500 -1.88% ✓ $93.5K
Jun 17, 2025 Jun 18, 2025 Silva Paul M Director Neutral 52.5 - 0.00% ✗ -
May 15, 2025 May 19, 2025 Bredt David Chief Scientific Officer Sell 45.0 -8,500 -1.85% ✓ $81.3K
Apr 15, 2025 Apr 16, 2025 Bredt David Chief Scientific Officer Sell 45.0 -8,500 -1.81% ✓ $81.3K
Apr 1, 2025 Apr 3, 2025 Sevigny Jeffrey Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 14, 2025 Mar 17, 2025 Bredt David Chief Scientific Officer Sell 45.0 -8,500 -1.78% ✓ $92.2K
Mar 12, 2025 Mar 13, 2025 Ignelzi Troy A. CFO Buy 95.0 +10,000 100.00% ✗ $101K
Mar 12, 2025 Mar 13, 2025 Young Wendy B. Director Buy 95.0 +6,000 100.00% ✗ $61.2K
Mar 3, 2025 Mar 5, 2025 Gault Cheryl COO Neutral 85.0 +13,987 8.86% ✗ -
Mar 5, 2025 Sevigny Jeffrey Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 4, 2025 Ignelzi Troy A. CFO Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 4, 2025 Yeleswaram Krishnaswamy Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 4, 2025 Bredt David Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 4, 2025 Ceesay Abraham CEO Neutral 52.5 - 0.00% ✗ -
Feb 3, 2025 Feb 4, 2025 Gault Cheryl COO Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 Nov 7, 2024 Young Wendy B. Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 Nov 7, 2024 PEREZ ROBERT J Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 Nov 7, 2024 Silva Paul M Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 Nov 7, 2024 Sanchez Ramiro Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 PEREZ ROBERT J Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 Silva Paul M Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 Sanchez Ramiro Director Neutral 52.5 - 0.00% ✗ -
Nov 7, 2024 Young Wendy B. Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2024 Jul 3, 2024 HEALY JAMES Director Buy 87.5 +44,032 2.26% ✗ $1.1M
Jun 10, 2024 Jun 10, 2024 ARCH Venture Partners XII, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Galer Bradley S. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Gault Cheryl Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Bredt David Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Yeleswaram Krishnaswamy Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 10, 2024 Third Rock Ventures V, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Ceesay Abraham CEO Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 10, 2024 HEALY JAMES Director Buy 100.0 +558,824 40.12% ✗ $9.5M
Jun 6, 2024 Jun 10, 2024 Ignelzi Troy A. CFO Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Huber Reid M Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 ARCH Venture Partners XII, LLC 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Galer Bradley S. Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Tong Jeffrey K Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Gault Cheryl Chief Operations Officer Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 HEALY JAMES Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Bredt David Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Yeleswaram Krishnaswamy Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Third Rock Ventures V, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 MARAGANORE JOHN Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Burrell Terry-Ann Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 PAUL STEVEN M Director Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Ceesay Abraham CEO Neutral 52.5 - 0.00% ✗ -
Jun 6, 2024 Ignelzi Troy A. CFO Neutral 52.5 - 0.00% ✗ -